Current Psychopharmacology
Title:Preface
Volume: 6
Author(s): Silvio Bellino*Maria Laura De Rosa
Affiliation:
- Centre for Personality Disorders, Department of Neuroscience University of Turin, Turin,Italy
Export Options
About this article
Cite this article as:
Bellino Silvio*, Rosa Laura De Maria, Preface, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/221155600601170405213718
DOI https://dx.doi.org/10.2174/221155600601170405213718 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
9
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia
Current Alzheimer Research Nitric Dioxide as Biologically Important Radical and its Role in Molecular Mechanism of Pancreatic Inflammation
Current Pharmaceutical Analysis Altered Mesolimbic Dopamine System in THC Dependence
Current Neuropharmacology Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Identifying Patterns of Psychopathology and Pointing the Way to Effective Interventions
Adolescent Psychiatry Promotion of Remyelination by Immunoglobulins: Implications for the Treatment of Multiple Sclerosis
Current Pharmaceutical Design Problematic Use of the Mobile Phone: A Literature Review and a Pathways Model
Current Psychiatry Reviews The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Hemichannels in the Neurovascular Unit and White Matter Under Normal and Inflamed Conditions
CNS & Neurological Disorders - Drug Targets Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
Current Alzheimer Research The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Introduction from the Editor-In-Chief
Current Neurovascular Research Sympathetic Nervous System, Genes and Human Essential Hypertension
Current Neurovascular Research From the Editors Perspective:New Directions and New Sources for Stem Cells [Hot Topic: Stem Cells (Guest Editor: Feng C. Zhou)]
Current Neurovascular Research Dendritic Cell Endothelium Interaction in Autoimmunity
Current Pharmaceutical Design Buprenorphine-Mediated Transition from Opioid Agonist to Antagonist Treatment: State of the Art and New Perspectives
Current Drug Abuse Reviews Cathinone Neurotoxicity (“The “3Ms”)
Current Neuropharmacology Antisense Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid
Current Alzheimer Research The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Current Alzheimer Research